Shukra Pharmaceuticals

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue24.8819.4512.263.906.58
Expenses20.179.937.043.105.70
EBITDA5.3310.115.811.531.69
EBIT4.769.605.290.860.98
Profit Before Tax4.709.535.230.800.88
Net Profit4.719.423.990.490.54
Financial Ratios
Operating Profit Margin21.63%53.52%53.40%47.80%30.22%
Net Profit Margin19.12%49.87%36.67%15.41%9.71%
Earning Per Share (Diluted)1.478.613.640.110.25
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ